Evaluate Pharma Landing Page

WHY EVALUATE PHARMA?

Trusted across the industry and used by all the leading players, Evaluate Pharma is the gold standard for consensus forecasts. Transform your approach to asset valuation, portfolio optimisation and strategic decision-making with a detailed and accurate view of biopharma’s clinical and commercial landscape – past, present and future.

Request a free demo

INDUSTRY-LEADING
CONSENSUS KNOWLEDGE

Evaluate Pharma goes beyond traditional forecasts and incorporates additional data and functionality that enable you to uncover deeper insights, and fully understand and model the market. You can access:

Forecasts from over 100 brokers (78 from exclusive partnerships)
An extensive archive of 1.5m+ historical forecasts for 10,000+ products
Historic sales, projections for pipeline assets, financial performance and deals
Dynamic summary pages, interactive dashboards, and much more

Enquire now

HOW CAN EVALUATE SUPPORT YOU?

Complete the form and you’ll be contacted by an Evaluate colleague who will provide a free product demonstration that’s relevant to your needs.

Business Email:

Job Title:

Country:

I would like to receive Evaluate industry & market reports, and the latest news from Evaluate. I agree to the privacy policy.

utm_campaign:

utm_source:

utm_medium:

utm_content:

ga.cid:

Latest Form Fill Webpage:

utm_term:

State:

First Name:

Last Name:

Company Name:

Tel:

ENHANCED METHODOLOGIES
& VISUALISATIONS

Highly transparent and interrogatable methodologies, data sets and sources.
Application of methodologies to enable robust trending that accommodate changes in sample composition.
Data is verified and calibrated to provide cross comparisons against industry methodologies.
Unique ability to link consensus forecasts directly to the pipeline to allow quick analysis of forecasts at indication, therapeutic area and MOA levels.
The most comprehensive company model coverage and tools to conduct strategic / financial analysis.